NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
31 hedge funds and large institutions have $1.68M invested in Navidea Biopharmaceuticals Inc. in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
75% less call options, than puts
Call options by funds: $96K | Put options by funds: $379K
Holders
31
Holding in Top 10
–
Calls
$96K
Puts
$379K
Top Buyers
| 1 | +$147K | |
| 2 | +$51K | |
| 3 | +$25K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.5K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
+$13K |
Top Sellers
| 1 | -$76K | |
| 2 | -$48K | |
| 3 | -$35.5K | |
| 4 |
Two Sigma Investments
New York
|
-$33.8K |
| 5 |
ACM
Allred Capital Management
Dallas,
Texas
|
-$11.7K |